Brief exposure of mice to 60 Hz magnetic fields reduces the analgesic effects of the neuroactive steroid, 3α-hydroxy-4-pregnen-20-one

Neuroscience Letters

Volumn 257, Issue 3, 1998, Pages 155-158

  Kavaliers, M ^a   Wiebe, J P ^a   Ossenkopp, K P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

60 Hz; Analgesia; Calcium channel; Extremely low frequency magnetic field; Neuroactive steroids

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CALCIUM CHANNEL; STEROID;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPOSURE; MAGNETIC FIELD; MOUSE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STEROID METABOLISM;

20-ALPHA-DIHYDROPROGESTERONE; ANALGESICS; ANIMALS; CEREBRAL CORTEX; ELECTROMAGNETIC FIELDS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEURONS;

EID: 0032484177     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00835-0     Document Type: Article

References (29)

1. Bawin S.M., Satmary W.M., Jones R.A., Adey W.R., Zimmerman G. Extremely-low-frequency magnetic fields disrupt rhythmic slow activity in rat hippocampal slices. Bioelectromagnetics. 17:1996;388-395.
2. Beck C.A., Wolfe M., Murphy L., Wiebe J.P. Acute, nongenomic actions of the neuroactive gonadal steroid, 3α-hydroxy-4-pregnen-20-one (3αHP), on FSH release in perifused rat anterior pituitary cells. Endocrine. 6:1997;221-229.
3. Crawley J.N., Glowa J.R., Majewska M.D., Paul S.M. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398:1986;382-385.
4. Dhanvantrai S., Wiebe J.P. Suppression of follicle-stimulating hormone by the gonadal and neurosteroid, 3α-hydroxy-4-pregnen-20-one involves actions at the level of the gonadatrope membrane/calcium channel. Endocrinology. 134:1994;371-376.
5. Frye C.A., Duncan J.E. Progesterone metabolites effective at the GABA-A receptor complex attenuate pain sensitivity in rats. Brain Res. 643:1994;194-203.
6. Frye C.A., VanKeuren K.R., Rao P.N., Erskine M.S. Analgesic effects of the neurosteroid 3α-androstanediol. Brain Res. 709:1996;1-9.
7. George M.S., Guidotti A., Rubinow D., Pan B., Mikalauskas K., Post R.M. CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol. Psychiat. 35:1994;775-780.
8. Haley J.T., McCormick W.S. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
9. Kavaliers M., Ossenkopp K.-P. Calcium channel involvement in magnetic field inhibition of morphine-induced analgesia. Naunyn-Schmiedbergs Arch. Pharmacol. 336:1987;308-315.
10. Kavaliers M., Ossenkopp K.-P. Day-night rhythms of opioid and non-opioid stress-induced analgesia: differential inhibitory effects of exposure to magnetic fields. Pain. 32:1987;223-229.
11. Kavaliers M., Wiebe J.P. Analgesic effects of the progesterone metabolite, 3α-hydroxy-5α-pregnan-20-one and possible modes of action in mice. Brain Res. 415:1987;393-398.
12. Kavaliers M., Ossenkopp K.-P., Tysdale D.M. Evidence for the involvement of protein kinase C in the modulation of morphine-induced analgesia and the inhibitory effects of exposure to 60-Hz magnetic fields in the snails, Cepaea nemoralis. Brain Res. 554:1991;65-71.
13. Kavaliers M., Wiebe J.P., Galea L.A.M. Reduction of predator odor-induced anxiety in mice by the neurosteroid 3α-hydroxy-4-pregnen-20-one (3αHP). Brain Res. 646:1994;140-144.
14. Kavaliers, M., Choleris, E., Prato, F.S. and Ossenkopp, K.-P., Evidence for the involvement of nitric oxide and nitric oxide synthase in the modulation of opioid-induced antinociception and the inhibitory effects of exposure to 60-Hz magnetic fields in the land snail, Brain Res., (1998) in press.
15. A receptor: mechanisms of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
16. Mok W.M., Herschowkitz S., Krieger N.R. Evidence that 3α-hydroxy-5α-pregnan-20-one is the metabolite responsible for anesthesia induced by 5α-pregnanedione in the mouse. Neurosci. Lett. 135:1992;145-148.
17. Ossenkopp K.-P., Kavaliers M. Morphine-induced analgesia and exposure to 60 Hz magnetic fields: inhibition of nocturnal analgesia is a function of magnetic field intensity. Brain Res. 418:1987;356-360.
18. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., Pasini A., Pupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiat. 155:1998;910-913.
19. Rupprecht R., Hauser C.A.E., Trapp T., Holsboer F. Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J. Steroid. Biochem. Mol. Biol. 56:1996;163-168.
20. Sartuci F., Bonfiglio L., Del Seppia C., Luschi P., Ghione S., Murri L., Papi F. Changes in pain perception and pain-related somatosensory evoked potentials in humans produced by exposure to oscillating magnetic fields. Brain Res. 769:1997;362-366.
21. Savitz D., Boyle C.A. Prevalence of depression among electrical workers. Am. J. Indust. Med. 25:1994;165-176.
22. A receptor α4subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 392:1998;926-930.
23. Triggle D.J., Rample O. 1,4-Dihyydropiridine activators and antagonists: structural and functional distinctions. Trends Pharmacol. Sci. 10:1989;507-511.
24. 2+channels. Trends Pharamcol. Sci. 12:1991;349-354.
25. Verkasalo P.K., Kaprio J., Varjonen J., Romanov K., Heikkila K., Koskenuvo M. Magnetic fields of transmission lines and depression. Am. J. Epidemiol. 146:1998;1037-1045.
26. Wiebe J.P., Kavaliers M. Analgesic effects of the putative FSH-suppressing gonadal steroid, 3α-hydroxy-4-pregnen-20-one: possible modes of action. Brain Res. 461:1988;150-157.
27. Wiebe J.P., Dhavantari S., Watson P.H., Hang Yu. Suppression in gonadotropes of gonadotropin-releasing hormone-stimulated follice-stimulating hormone release by gonadal- and neurosteroid 3α-hydroxy-4-pregnen-20-one involves cytosolic calcium. Endocrinology. 134:1994;377-382.
28. Wiebe J.P., Deline C., Buckingjham K.D., Dave V., Strothers J.B. Synthesis of the allylic gonadal steroids, 3α-hydroxy-4-pregnen-20-one and 3α-hydroxy-4-androsten-17-one, and of 3α-hydroxy-5α-pregnan-20-one. Steroids. 45:1985;39-51.
29. Wiebe J.P., Boushy D., Wolfe M. Synthesis, metabolism and levels of the neuroactive steroids, 3α-hydroxy-4-pregnen-20-one (3αHP), in rat pituitaries. Brain Res. 764:1997;158-166.